Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Ian R. Peake"'
Autor:
Ahmad H. Mufti, Kenichi Ogiwara, Laura L. Swystun, Jeroen C.J. Eikenboom, Ulrich Budde, Wilma M. Hopman, Christer Halldén, Jenny Goudemand, Ian R. Peake, Anne C. Goodeve, David Lillicrap, Daniel J. Hampshire
Publikováno v:
Blood Advances, Vol 2, Iss 13, Pp 1585-1594 (2018)
Abstract: Plasma levels of von Willebrand factor (VWF) vary considerably in the general population and this variation has been linked to several genetic and environmental factors. Genetic factors include 2 common single nucleotide variants (SNVs) loc
Externí odkaz:
https://doaj.org/article/e7b7ce86e1684fcc80e00e70075d1ced
Autor:
Daniel J. Hampshire, George J. Burghel, Jenny Goudemand, Laura C. S. Bouvet, Jeroen C. J. Eikenboom, Reinhard Schneppenheim, Ulrich Budde, Ian R. Peake, Anne C. Goodeve
Publikováno v:
Haematologica, Vol 95, Iss 12 (2010)
Externí odkaz:
https://doaj.org/article/62f86cd2f2b34f259b073543b6ec6dba
Autor:
Anne Goodeve, Marc Trossaert, Ulrich Budde, Frank W.G. Leebeek, Riitta Lassila, Gholamreza Toogeh, Peyman Eshghi, Flora Peyvandi, Jeroen Eikenboom, Renato Marino, Cristina Santoro, Eva Zetterberg, Bijan Keikhaei, Andreas Tiede, Nikolas Nikšić, Imre Bodó, Minoo Ahmadinejad, Giancarlo Castaman, Alberto Tosetto, Ian R. Peake, Jenny Goudemand, Olga Benitez, Augusto B. Federici, Pier Mannuccio Mannucci, Mehran Karimi, Maria Fernanda Lopez Fernandez, Luciano Baronciani, Wolf A Hassenpflug, Florian Oyen, Hamid Hoorfar, Andrea Cairo, Zahra Badiee, Reinhard Schneppenheim, Mohammad-Reza Baghaipour
Publikováno v:
Blood Adv
Blood advances, 5(15), 2987-3001. American Society of Hematology
Blood Advances, 5(15), 2987-3001. ELSEVIER
Blood advances, 5(15), 2987-3001. American Society of Hematology
Blood Advances, 5(15), 2987-3001. ELSEVIER
Type 3 von Willebrand disease (VWD3) is a rare and severe bleeding disorder characterized by often undetectable von Willebrand factor (VWF) plasma levels, a recessive inheritance pattern, and heterogeneous genotype. The objective of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ec67b9463a428c1d34effb2c7805a74
https://europepmc.org/articles/PMC8361454/
https://europepmc.org/articles/PMC8361454/
Autor:
Zahra Badiee, Omidreza Zekavat, Reinhard Schneppenheim, Gholamreza Toogeh, Peyman Eshghi, Hamid Hoorfar, Bijan Keikhaei, Andreas Tiede, Luciano Baronciani, Jenny Goudemand, Mehran Karimi, Maria Gabriella Mazzucconi, Maria Fernanda Lopez Fernandez, Marc Trossaert, Massimo Morfini, Jeroen Eikenboom, Cosimo Ettorre, Eva Zetterberg, Imre Bodó, Anne Goodeve, Alberto Tosetto, Ian R. Peake, Ulrich Budde, Pier Mannuccio Mannucci, Augusto B. Federici, Johannes Oldenburg, Erik Berntorp, Javier Battle, Charles R. M. Hay, Rafael Parra Lòpez, Giancarlo Castaman, Flora Peyvandi, Mohammad Reza Baghaipour, Riitta Lassila, Frank W.G. Leebeek
Publikováno v:
Journal of Thrombosis and Haemostasis, 18(9), 2145-2154. WILEY
Journal of Thrombosis and Haemostasis, 18(9), 2145-2154. Wiley-Blackwell Publishing Ltd
Journal of Thrombosis and Haemostasis, 18(9), 2145-2154. Wiley-Blackwell Publishing Ltd
Background Type 3 von Willebrand's disease (VWD) patients present markedly reduced levels of von Willebrand factor and factor VIII. Because of its rarity, the bleeding phenotype of type 3 VWD is poorly described, as compared to type 1 VWD. Aims To ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::539b43dc591d07131948ed6bc02f6e50
http://hdl.handle.net/1887/3184909
http://hdl.handle.net/1887/3184909
Autor:
Ahmad H, Mufti, Kenichi, Ogiwara, Laura L, Swystun, Jeroen C J, Eikenboom, Ulrich, Budde, Wilma M, Hopman, Christer, Halldén, Jenny, Goudemand, Ian R, Peake, Anne C, Goodeve, David, Lillicrap, Daniel J, Hampshire
Publikováno v:
Blood advances. 2(13)
VWF variants c.2365A>G and c.2385T>C independently influence VWF biosynthesis and clearance, increasing VWF plasma levels.Commonly inherited VWF variants can directly influence the protein and may contribute to hemostatic and thrombotic disease risk/
Autor:
Rachael E. Coyle, Nawal S. Al-Shammari, Türkiz Gürsel, Sarah L. Messenger, Ahlam M. Al-Buhairan, Ian R. Peake, Anne Goodeve, Daniel J. Hampshire, Adel M. Abuzenadah, Michaela Eckert, Ashley Cartwright, Ulrich Budde, Jørgen Ingerslev
Publikováno v:
Thrombosis and Haemostasis. 110:264-274
SummarySeveral cohort studies have investigated the molecular basis of von Willebrand disease (VWD); however, these have mostly focused on European and North American populations. This study aimed to investigate mutation spectrum in 26 index cases (I
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 1(3)
Autor:
Ian R. Peake
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 1
Autor:
Marc Trossaert, Jenny Goudemand, Maria Fernanda Lopez Fernandez, Peyman Eshghi, Mohammad-Reza Baghaipour, Rafael Parra Lòpez, Hamid Hoorfar, Ian R. Peake, Augusto B. Federici, Alberto Tosetto, Bijan Keikhaei, Zahra Badiee, Renato Marino, Frank W.G. Leebeek, Giancarlo Castaman, C. R. M. Hay, Simona Maria Siboni, Mehran Karimi, Riitta Lassila, Flora Peyvandi, Cristina Santoro, Jeroen Eikenboom
Publikováno v:
Blood. 132:2464-2464
Although rare, type 3 von Willebrand disease (VWD3) is of major interest because of its severe clinical presentation, the need for replacement therapy with von Willebrand Factor (VWF) concentrates and the risk of anti-VWF inhibitors. To better charac